VOLUME 17 NUMBER 11 NOVEMBER 2016 nature immunology MAIT cells are a specialized T cell lineage that detects vitamin-B derivatives such as 5-OP-RU (5-(2-oxopropylideneamino)-6-dribitylaminouracil) presented by the major-histocompatibilitycomplex-class-I-related protein MR1 (refs. 1-5). Both the T cell antigen receptor (TCR) expressed by MAIT cells and MR1 are evolutionarily conserved, suggestive of strong selective pressure to maintain MAIT-cell-mediated immunity 6, 7 . These cells express a semiinvariant TCR comprising an invariant TRAV1-2 TRAJ33 chain (TCR α-chain variable region 1-2 and TCR α-chain joining region 33) in humans (TRAV1 and TRAJ33 in mice) and a constrained range of TCRβ chains, with a bias toward TRBV6 (TCR β-chain variable region 6) and TRBV20 in humans (TRBV19 and TRBV13 in mice). MAIT cells are abundant, representing ~5-50% of T cells in various human tissues, although their numbers vary widely among people [8] [9] [10] [11] . Moreover, they have important roles in immunity to infection with a broad range of pathogens 9, 12, 13 and are also involved in autoimmunity and other inflammatory responses 14 . Given the functional importance of MAIT cells and their wide variability, it is important to understand the factors that control their development and maturation.
MAIT cells are a specialized T cell lineage that detects vitamin-B derivatives such as 5-OP-RU (5-(2-oxopropylideneamino)-6-dribitylaminouracil) presented by the major-histocompatibilitycomplex-class-I-related protein MR1 (refs. [1] [2] [3] [4] [5] . Both the T cell antigen receptor (TCR) expressed by MAIT cells and MR1 are evolutionarily conserved, suggestive of strong selective pressure to maintain MAIT-cell-mediated immunity 6, 7 . These cells express a semiinvariant TCR comprising an invariant TRAV1-2 TRAJ33 chain (TCR α-chain variable region 1-2 and TCR α-chain joining region 33) in humans (TRAV1 and TRAJ33 in mice) and a constrained range of TCRβ chains, with a bias toward TRBV6 (TCR β-chain variable region 6) and TRBV20 in humans (TRBV19 and TRBV13 in mice). MAIT cells are abundant, representing ~5-50% of T cells in various human tissues, although their numbers vary widely among people [8] [9] [10] [11] . Moreover, they have important roles in immunity to infection with a broad range of pathogens 9, 12, 13 and are also involved in autoimmunity and other inflammatory responses 14 . Given the functional importance of MAIT cells and their wide variability, it is important to understand the factors that control their development and maturation.
MAIT cells develop in the thymus, where they undergo positive selection and lineage commitment after interacting with MR1-expressing CD4 + CD8 + double-positive (DP) thymocytes 1, 4, 15 . While phenotypically distinct subsets of MAIT cells have been defined, including CD4 + , CD4 − CD8 − and CD4 − CD8 + populations 11, 16 , the developmental pathway that underpins the production and maturation of MAIT cell has remained unclear. In human blood, MAIT cells are often defined by expression of TRAV1-2 in conjunction with the NK cell receptor CD161 and the cytokine receptor chain CD218 (IL-18Rα) 8, [17] [18] [19] . However, the time at which these markers are acquired during the development of MAIT cells is unknown, so it is unclear if these can be used to study MAIT-cell development in the thymus. With the development of MR1 tetramers it is now possible to specifically detect and isolate MAIT cells in mice and humans 2, 16, 20, 21 .
A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage
Here we identify previously unknown populations of MAIT cells in mouse and human thymus and delineate a three-stage developmental pathway in both species, defining key control points and factors that regulate the generation of these cells. Thus, we have mapped the development of MAIT cells in mice and humans and have demonstrated the potential for this model to elucidate how this process is regulated.
RESULTS

Identification of mouse thymic MAIT-cell progenitors
To understand MAIT cell development, we used MR1-5-OP-RU tetramers to characterize MAIT cells in the thymus and peripheral lymphoid tissues of mice. This identified a population of CD24 + CD44 − MAIT cells that were present exclusively in thymus, whereas in peripheral organs, essentially all MAIT cells were CD24 − CD44 + (Fig. 1a) . Control MR1 tetramers loaded with the non-agonist folate derivative Ac-6-FP (acetyl-6-formylpterin) 22 failed to stain MAIT cells from these organs (Fig. 1a) , which confirmed the specificity of this staining. Single-cell TCR-sequence analysis of the CD24 + CD44 − and CD24 − CD44 + populations indicated that both populations used an invariant TRAV1-TRAJ33 TCR α-chain paired with a limited range of TCR β-chains (TRBV13 and TRBV19) (Supplementary Table 1) , characteristic of the MAIT-cell lineage 4 .
Comparison of CD24 + CD44 − and CD24 − CD44 + MAIT cells from the thymus indicated that CD24 + CD44 − MAIT cells had low expression of integrin α E β 7 (CD103), the cytokine receptors CD122 (IL-2Rβ), CD127 (IL-7Rα) and CD218 (IL-18R), the costimulatory molecule CD278 (ICOS) and the activating NK cell receptor NK1.1 (CD161), but higher expression of the memory marker CD62L and activation marker CD69 than that of CD24 − CD44 + MAIT cells (Fig. 1b) . Staining of thymus enriched for MAIT cells through the use of the MR1-5-OP-RU tetramer and magnetic beads indicated an additional subpopulation of CD24 − CD44 − MAIT cells (Fig. 1c) . Thus, on the basis of their cell-surface phenotype, we tentatively defined these populations as stage 1 (CD24 + CD44 − ), stage 2 (CD24 − CD44 − ) and stage 3 (CD24 − CD44 + ) MAIT cells (Fig. 1c) . The vast majority of stage 1 thymic MAIT cells were small (FSC lo ) CD4 + or CD4 + CD8 + DP cells (Fig. 1c) , a phenotype typically associated with immature T cells in the thymus that also defines the earliest stage in the development of CD1d-restricted NKT cells 23 . Stage 2 cells were larger and mostly CD4 + CD8 − , whereas stage 3 MAIT cells were the largest and resembled mature MAIT cells in peripheral organs, being mostly CD4 − CD8 − or CD8 + (Fig. 1a,c) . Most CD8 + MAIT cells in thymus expressed CD8αβ heterodimers, while those in the periphery expressed CD8αα homodimers or CD8αβ heterodimers (Fig. 1a) , which suggested further extrathymic maturation of MAIT cells. Collectively, these data supported the proposal of three distinct stages of MAIT-cell development within mouse thymus.
Functionally mature stage 3 MAIT cells arise through ontogeny
To investigate the developmental progression of the three stages of thymic MAIT cells, we performed an ontogeny study of thymic MAIT cell subsets in mice at 2, 4 and 8 weeks of age. Stage 1 CD24 + CD44 − MAIT cells were the main subset (>50%) at 2 weeks; their abundance decreased to ~30% at 4 weeks and ~10% of thymic MAIT cells in 8-week-old adult mice (Fig. 2a,b) . Conversely, the proportion of stage 3 CD24 − CD44 + MAIT cells was low (~20%) at 2 weeks and gradually increased with age (~60% at 4 weeks and ~80% at 8 weeks) (Fig. 2a,b) , in support of the concept of developmental progression of MAIT cells from stage 1 to stage 3.
To determine the stage at which MAIT cells gained functional maturity, we assessed the expression of transcription factors known to regulate the cytokines expressed by these cells. Stage 1 and stage 2 cells had low expression of RORγt and T-bet (Fig. 2c) , which suggested they had limited capacity to secrete IL-17 and interferon-γ (IFN-γ) 15 , while stage 3 MAIT cells expressed either RORγt or T-bet (Fig. 2c) , suggestive of functional competence. Analysis of reporter mice expressing RORγt tagged with green fluorescent protein confirmed that only stage 3 MAIT cells expressed this reporter ( Supplementary  Fig. 1 ). The proportion of stage 3 MAIT cells that expressed RORγt or T-bet did not change substantially throughout ontogeny (data not shown). Stimulation of MAIT cells with the phorbol ester PMA and ionomycin revealed that stage 3 MAIT cells, but not stage 1 or stage 2 MAIT cells, were capable of producing IL-17 and IFN-γ (Fig. 2d) . Accordingly, the transition to stage 3 correlated with the acquisition of functional potential by mouse MAIT cells (Fig. 2d) , in support of the concept that the stage 1 and stage 2 MAIT cells were immature precursors of MAIT cells.
Development of MAIT cells from stage 1 to stage 3
To directly investigate the precursor-progeny relationship of the three stages of thymic MAIT cells, we established an in vitro MAITcell-development system using an adaptation of a co-culture system of OP9 mouse bone marrow stromal cells and thymocytes 24 . Because the number of cells was very low, we first used mice with transgenic expression of the TRAV1-TRAJ33 TCRα chain on a TCRα-null background, in which thymic MAIT cells were far more abundant (Supplementary Fig. 2 ). After 5 d of co-culture with OP9 cells, stage 1 MAIT cells sorted by flow cytometry had begun to differentiate into stage 2 and stage 3 cells (Fig. 3) . Similarly, many stage 2 MAIT cells had progressed to stage 3, whereas stage 3 cells maintained their mature CD24 − CD44 + phenotype (Fig. 3) . Optimal differentiation from stage 1 and stage 2 MAIT cells into stage 3 MAIT cells required the presence OP9 cells (Fig. 3) , indicative of a key role for stromalcell-derived factors in this process. We also cultured stage 1, stage 2 and stage 3 MAIT cells with OP9 cells engineered to express the Notch-receptor ligand DL1 and found that signaling via DL1 was not required for the maturation of TCR + precursors of MAIT cells (data not shown). The addition of an MR1-blocking antibody completely abolished the progression of stage 1 MAIT cells to stage 3 and partially inhibited the differentiation or survival of stage 2 and stage 3 cells, as reflected by a sharp reduction in the number of cells by day 5 (Fig. 3) . These data were consistent with the lack of MAIT cells in MR1-deficient mice 1, 11, 16 and indicated that the expression of MR1 was critical for both the initial development and further differentiation and/or survival of these MAIT cells.
We also isolated MAIT-cell subsets from wild-type mice and cultured them with OP9 cells. Because these cells were less frequent, we were unable to isolate sufficient numbers of the intermediate, stage 2 cells. Nonetheless, stage 1 cells progressed to stages 2 and 3 after 5 d of co-culture with OP9 cells, whereas stage 3 cells maintained their mature phenotype (Fig. 3) , which indicated that they had a developmental profile and kinetics similar to those of the cells with transgenic expression of the TRAV1-TRAJ33 TCR. These data indicated that the differentiation of mouse MAIT cells could be defined by a three-stage sequential pathway from CD24 + CD44 − cells (stage 1), via CD24 − CD44 − cells (stage 2), to CD24 − CD44 + cells (stage 3). a residual population of MAIT cells remains in mice deficient in PLZF (PLZF-null mice) 16 . In wild-type mice, PLZF was not detected in stage 1 MAIT cells, had heterogeneous expression in stage 2 MAIT cells and was fully expressed in stage 3 MAIT cells (Fig. 4a) . In PLZF-null mice, thymic stage 1 and stage 2 MAIT cells were intact, whereas stage 3 MAIT cells were completely absent, in contrast to results obtained for wild-type mice, in which stage 3 MAIT cells were the main population (Fig. 4b,c) . Residual MAIT cells in the periphery of PLZF-null mice were predominantly CD24 − CD44 − and CD4 + CD8 − (Fig. 4b ) and lacked expression of CD218, CD127 and CD103 (data not shown), which indicated that they were blocked at stage 2. Stimulation (with PMA and ionomycin) of the residual MAIT cells isolated from thymus, spleen and lymph nodes of PLZF-null mice did not induce cytokine secretion, in contrast to the cytokine secretion by MAIT cells isolated from wild-type mice, which expressed either IL-17A or IFN-γ (Fig. 4d) . This suggested that progression to stage 2 was PLZF independent but maturation to stage 3 and acquisition of effector function was PLZF dependent and could occur after stage 2 cells left the thymus, because in the absence of the PLZF-driven maturation, MAIT cells remained immature in the thymus and peripheral tissues.
Control of the development of MAIT cells by microRNA
Because microRNAs (miRNAs) have important roles in regulating gene expression and profoundly influence the development and function of NKT cells 28 , we next assessed the role of Drosha, a member of the RNase III superfamily that initiates the processing of miRNA in the nucleus 28, 29 , in MAIT-cell maturation. For this we used Drosha fl/fl Cd4-Cre mice (with loxP-flanked alleles encoding Drosha deleted by Cre recombinase expressed transgenically under the control of the T cell-specific Cd4 promoter), which have a substantial reduction in the expression of Drosha from the CD4 + CD8 + DP thymocyte stage 30 A r t i c l e s thymus, stage 3 CD44 + MAIT cells were still detectable in the spleen and lymph nodes of these mice, albeit at a diminished abundance relative to that of Drosha fl/+ Cd4-Cre mice (Fig. 5a,b) . We also observed significantly fewer NKT cells in thymus, spleen and lymph nodes of Drosha fl/fl Cd4-Cre mice than in those of Drosha fl/+ Cd4-Cre mice (P < 0.01; Supplementary Fig. 3a) , consistent with observations obtained with mice deficient in Dicer (another member of the RNase III superfamily) 31 . Thus, we concluded that miRNAs controlled MAIT-cell development beyond stage 1.
Impairment of MAIT-cell development in germ-free mice MAIT cells have been reported to be absent from germ-free mice 1 ; thus, we investigated whether a developmental block occurred at a specific stage by comparing germ-free mice with specific-pathogen-free (SPF) control mice. The number of MAIT cells in the thymus and spleen of germ-free mice was significantly lower than that in SPF mice (Fig. 5c,d) . Moreover, thymic stage 3 CD44 + MAIT cells were diminished in abundance in germ-free mice relative to that in SPF mice (Fig. 5c,d ), while stage 1 CD24 + CD44 − MAIT cells were greater in frequency, but not in number, in germ-free mice than in SPF mice ( Fig. 5c and data not shown). In contrast, there was no difference in the number of NKT cells in germ-free mice versus that in SPF controls (Supplementary Fig. 3b ).
Since IL-18 expression is diminished in germ-free mice 32 and because MAIT cells upregulated their expression of IL-18R during their intrathymic maturation (Fig. 1) , we investigated whether loss of IL-18 affected MAIT-cell development. Similar to germ-free mice, IL-18-deficient mice displayed a reduced number of thymic MAIT cells and a decrease in the frequency of thymic stage 3 CD24 − CD44 + MAIT cells, with a greater frequency, but not number, of stage 1 CD24 + CD44 − MAIT cells, relative to that of wild-type mice (Supplementary Fig. 4a,b) . Furthermore, there was a significantly lower abundance of MAIT cells in the spleen and lymph nodes of IL-18-deficient mice than in those of wild-type mice (P < 0.001; Supplementary Fig. 4b) . Paradoxically, IL-18Rα-deficient mice showed normal development and maturation of MAIT cells within the thymus, spleen and lymph nodes (Supplementary Fig. 4c,d) .
Comparison of IL-18-deficient mice and IL-18Rα-deficient mice can be complicated because IL-18 can signal through another receptor, the Na-Cl co-transporter 33 , whereas another cytokine, IL-37, can signal through IL-18R 34 . Thus, development and maturation of MAIT cell was impaired in germ-free mice, which suggested an important role for commensal bacteria and IL-18 in this process. 
A r t i c l e s
Over-representation of MAIT cells in CD1d-deficient mice Because MAIT cells and NKT cells have some similarities, such as a dependence on PLZF and selection by DP thymocytes, we assessed MAIT-cell development in CD1d-deficient mice that lack both CD1d and CD1d-restricted NKT cells. CD1d-deficient mice had more MAIT cells in the thymus, spleen ( Fig. 6 and Supplementary  Fig. 5 ) and liver (data not shown) than did wild-type mice on either the BALB/c background or the C57BL/6 background, and this was particularly apparent on the BALB/c background (Fig. 6) . As previously reported 16 ND, not detectable. *P < 0.1, **P < 0.01 and ***P < 0.001 (Mann-Whitney rank-sum U-test). Data are representative of three experiments (a), three independent experiments with a total of nine mice per group (b,c; mean ± s.e.m. in c) or two independent experiments with a total of six mice per group (d).
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A r t i c l e s co-receptor CD8 in BALB/c mice than in C57BL/6 mice, and this was seen in both wild-type mice and CD1d-deficient mice ( Fig. 6a and Supplementary Fig. 5 ). In terms of MAIT-cell development, while number of stage 1 and stage 2 MAIT cells was not altered in CD1d-deficient mice relative to that in wild-type mice, stage 3 CD24 − CD44 + MAIT cells were far more numerous in thymus and spleen of CD1d-deficient mice than in that of wild-type mice ( Fig. 6 and Supplementary Fig. 5) . Conversely, the number of NKT cells in the thymus and spleen of MR1-deficient mice was similar to that in wild-type mice (data not shown). Together these data suggested that MAIT cells compete with NKT cells for factors or a shared niche during their maturation in the thymus.
Identification of MAIT-cell precursors in the human thymus
We next investigated whether MAIT-cell development in humans follows a developmental pathway similar to that in mice. We analyzed MAIT cells in human thymus and umbilical cord blood and in peripheral blood from young donors (matched with thymus donors) and adult donors using human MR1-5-OP-RU tetramers in combination with other markers commonly used to identify MAIT cells, including TRAV1-2, CD161 and CD218 (refs. 8,17,18) . MAIT cells (defined as CD3 + TRAV1-2 + MR1-5-OP-RU-tetramer-positive) were detected in all human thymus samples, although they were much less frequent (<0.05%) in human thymus than in adult human blood (data not shown), in which they typically represent 2-5% of CD3 + T cells 16 . Because these cells were so infrequent in human thymus, we first enriched thymus samples for TRAV1-2 + cells through the use of magnetic beads; this yielded a distinct population of MAIT cells that ranged in frequency from 0.08% to 0.45% of TRAV1-2 + thymocytes (Fig. 7a,b) . The frequency of MAIT cells among TRAV1-2 + cells was greater in umbilical cord blood and blood from young and adult donors than in human thymus (Fig. 7a,b) , which suggested that (Fig. 7a,b) . The majority of MAIT cells in blood from young donors and in umbilical cord blood were CD218 + CD161 + (Fig. 7a) . Thus, CD218 − CD161 − MAIT cells were predominant in human thymus and gradually diminished in blood samples from increasingly mature donors (Fig. 7a,c) , which suggested that they were immature precursor cells. Furthermore, whereas blood MAIT cells were predominantly CD4 − CD8 − or CD4 − CD8 + (Fig. 7a) , roughly half of thymic MAIT cells were either CD4 + CD8 + or CD4 + CD8 − (Fig. 7a) . Moreover, analysis of paired thymus and blood samples showed that the frequency of CD4 + MAIT-cell populations was much greater in the thymus than in matched blood (Fig. 7d) . Accordingly, most MAIT cells in human thymus were markedly distinct from MAIT cells in blood.
We also performed an ontogeny study of MAIT cells in matched thymus and blood samples from 18 different donors ranging from 5 days of age to 14 years of age. This analysis indicated that the frequency of MAIT cells (among TRAV1-2 + cells) remain relatively low and stable in the thymus (0.1-0.3% of TRAV1-2 + cells) regardless of age (Fig. 7e) , while, in contrast, the frequency of MAIT cells gradually increased with age in peripheral blood (from 5 days to 14 years), from less than 1% to up to 60% of TRAV1-2 + cells and from less than 0.02% to up to 3.5% of CD3 + T cells (Fig. 7e,f) . Thus, we concluded that the characteristically large number of MAIT cells in human blood is a result of gradual peripheral population expansion with age.
Further analysis of human CD161 − MAIT cells on the basis of expression of the costimulatory receptor CD27 indicated that the CD161 − CD27 − subset was present exclusively in the thymus, whereas CD161 − CD27 + MAIT cells were detected at low frequency in umbilical cord blood (~22%) and blood from young donors (~13%) and were essentially absent in blood from adult donors (~1%) (Fig. 7a,g) 
A r t i c l e s
Conversely, CD161 + CD27 pos−lo MAIT cells were rare in the thymus (~10%) and abundant in the blood (Fig. 7a,g ). Thus, we tentatively defined three distinct stages of MAIT cell development in human thymus: stage 1 (CD161 − CD27 − ), stage 2 (CD161 − CD27 + ) and stage 3 (CD161 + CD27 pos-lo ). Further analysis demonstrated a decrease in the abundance of stage 1 and stage 2 MAIT cells and an increase in that of stage 3 MAIT cells in tissues from increasingly mature human donors (Fig. 7a,g ). In line with this maturation pathway, and similar to results obtained for mice, in humans, stage 1 MAIT cells were predominantly CD4 + CD8 + , stage 2 MAIT cells were CD4 + , CD4 + CD8 + or CD4 − CD8 + cells, and stage 3 MAIT cells were mostly CD4 − CD8 − or CD8 + (Fig. 8a) ; the last subset resembled MAIT cells found in human blood (Fig. 8a) . Collectively, our results indicated that the three-stage MAIT-cell-development pathway we identified in human thymus roughly paralleled the pathway we mapped for mouse thymus (Supplementary Fig. 6 ). Many peripheral CD8 + MAIT cells expressed CD8αα homodimers rather than CD8αβ heterodimers 18 (Fig. 8a) . Given that most human thymocytes express CD8αβ heterodimers, we investigated where in the three-stage development pathway human MAIT cells began to express CD8αα homodimers. Similar to MAIT cells in mouse thymus, essentially all CD8 + MAIT cells in human thymus expressed the CD8αβ heterodimer, regardless of whether they were at stage 1, stage 2 or stage 3 of development (Fig. 8a) A r t i c l e s thymus samples, a large proportion of blood MAIT cells were CD8αα + (Fig. 8a) . This distinct CD8 profile of thymic MAIT cells was consistent with published reports suggesting that CD8αα + MAIT cells develop from a pool of CD161 + CD8αβ + T cells 18, 19 . Furthermore, this also suggested that the stage 3 MAIT cells in human thymus were not recirculating cells from the periphery but were instead a recently developed population that arose from stage 2 CD161 − CD27 + MAIT cells.
Functional maturation begins at stage 3 in development We next investigated if the three stages of human thymic MAIT cells displayed a pattern of transcription-factor expression similar to that in MAIT cells at the same stages in mice. Akin to the expression of PLZF, T-bet and RORγt in mouse thymic MAIT cells, expression of these transcription-factors increased between stage 2 and stage 3 in human thymic MAIT cells (Fig. 8b) although mature MAIT cells did not have high expression of RORγt (Fig. 8b) . In contrast to mouse stage 3 MAIT cells, in which expression of T-bet and that of RORγt were mutually exclusive, in human stage 3 MAIT cells, these factors were co-expressed (Fig. 8b) . A small subset of stage 1 MAIT cells expressed RORγt, which probably reflected their recent transition from CD4 + CD8 + DP thymic precursors that were RORγt + (Fig. 8b) .
To investigate functional competence, we obtained MAIT cells from matched human thymus and blood samples, stimulated the cells with PMA and ionomycin and assessed their production of the cytokines IFN-γ, TNF and IL-17A. While a subset (<25%) of stage 3 MAIT cells from the thymus produced IFN-γ and TNF, the stage 3 cells from blood were superior in their cytokine production, with the majority (>80%) of cells producing both IFN-γ and TNF (Fig. 8c,d ). We were unable to detect IL-17A production by any of these MAIT-cell subsets (data not shown), which probably reflected the low expression of RORγt by these cells. Thus, human MAIT cells were functionally competent at stage 3 but continued their functional maturation extrathymically.
DISCUSSION
Here we have identified precursor populations of the MAIT cell lineage in the thymus and mapped a three-stage pathway in both mice and humans. In both species, only stage 3 cells produced cytokines, and these cells resembled MAIT cells in peripheral organs, although further extrathymic maturation occurred for human stage 3 cells. Given the presence of some stage 2 cells in human blood, especially in umbilical cord blood, and in PLZF-null mice, we suggest that MAIT cells might first emigrate from the thymus at stage 2 and continue their maturation and population expansion extrathymically.
Our data have provided a more complete view of MAIT-cell development than that provided by studies relying on surrogate phenotypic markers such as TRAV1-2 + CD161 + to identify MAIT cells in humans 19 or using transgenic TCR systems or RORγt to detect MAIT cells in mice 11, 35, 36 . For example, the use of surrogate markers to identify human MAIT cells excludes CD161 − stage 1 and stage 2 MAIT cells, which has limited published studies to the minor subset of mature stage 3 cells in human thymus 19 . Furthermore, we found that ~50% of TRAV1-2 + CD161 + cells from human thymus failed to bind MR1-5-OP-RU tetramer (data not shown), which suggested that many of these were not MAIT cells. Similarly, while the use of RORγt-green fluorescent protein combined with the memory marker CD44 identifies many of the mature stage 3 MAIT cells in mice 36 , this strategy would miss immature stage 1 and stage 2 CD44 − MAIT cells and mature stage 3 MAIT cells that lack RORγt.
There are some similarities between the development of MAIT cells and that of CD1d-restricted NKT cells. Both lineages depend on PLZF expression for normal maturation, and both are dependent on miRNAs regulated by Drosha. However, there are some important differences in the development of these lineages. First, expression of PLZF is high very early in NKT cell development, while it is downregulated in most mature NKT cells 25, 27 , with the exception of IL-4-producing NKT2 cells 37, 38 . In contrast, PLZF was expressed late in MAIT cell development and governed their final maturation step to generate functional stage 3 MAIT cells, and was maintained at high levels by these cells. After maturing, most NKT cells in mice upregulate their expression of NK1.1 and CD69 and are either CD4 + or CD4 − CD8 − . Conversely, most mature mouse MAIT cells lacked NK1.1 expression and downregulated CD69 expression upon maturation, and many expressed CD8. MAIT-cell maturation was impaired in germ-free mice, whereas NKT-cell maturation was intact; as has been shown before, the adaptor SAP ('signaling lymphocytic-activation molecule adaptor protein') is critical for NKT cell development 39 , whereas MAIT cells seem to be SAP independent 11 . Furthermore, our observation that MAIT cells were over-represented in CD1d (NKT cell)-deficient mice suggested that these cells might compete for an environmental niche. This might explain in part why CAST/EiJ mice, which have fewer NKT cells 40 , have more MAIT cells than do C57BL/6 mice 36 . It follows that careful consideration is needed for the study of NKT-cell-deficient mice, as these will differ from wild-type mice not only because they lack NKT cells but also because they have more MAIT cells.
While the developmental sequence for MAIT cells in mice had many parallels with that in humans, there were also some distinctions. Although we detected stage 3 MAIT cells in human thymus, these were in the minority and were only partially functional compared with stage 3 MAIT cells in mouse thymus. MAIT cells in human peripheral blood accumulated with age and also acquired greater cytokine-producing capacity, and many switched from being CD8αβ-expressing cells to being CD8αα-expressing cells. In further contrast to mouse MAIT cells, neither thymic MAIT cells nor blood MAIT cells from humans produced IL-17. Given that human MAIT cells isolated from the liver and female genital tract can produce IL-17 (refs. 10,41) , this suggested that further environment-dependent extrathymic maturation influences human MAIT-cell function. We hypothesize that this peripheral population expansion and maturation is shaped by exposure to microbial antigens over time, a hypothesis also supported by our studies of germ-free mice, which had significantly fewer stage 3 MAIT cells in the thymus and periphery than SPF mice had, and also by a published paper demonstrating microbemediated population expansion of peripheral MAIT cells in a mouse model of Salmonella infection 42 .
In summary, we have defined thymic precursors of the MAIT cell lineage. We have also mapped a three-stage pathway for MAIT-cell maturation in mice and humans controlled by developmental checkpoints and have identified key factors that control this process. Most importantly, this study will provide a foundation for future studies to better elucidate the factors that regulate the highly abundant, yet highly variable, MAIT-cell lineage.
METHODS
Methods and any associated references are available in the online version of the paper. 
